Genetic variants, haplotype determination, and function of novel alleles of CYP2B6 in a Han Chinese population

• DOI: 10.1016/j.heliyon.2024.e28952
• Publication Date: 2024-03-30T07:16:09Z
• Authors: Li-Qun Zhang; Xin-Yue Li; Lian-Guo Chen; Zhe Chen; Ren-Ai Xu; Jian-Chang Qian; Xiao-yang Zhou; Da-Peng Dai; Guo-Xin Hu; Jian-Ping Cai
• Keywords: Social sciences (General); H1-99; Q1-390; 03 medical and health sciences; CYP2B6; Science (General); 0302 clinical medicine; Haplotype; Genetic variant; Catalytic activity; Research Article

Amino acid variants in protein may result in deleterious effects on enzymatic activity. In this study we investigate the DNA variants on activity of CYP2B6 gene in a Chinese Han population for potential use in precision medicine. All exons in CYP2B6 gene from 1483 Chinese Han adults (Zhejiang province) were sequenced using Sanger sequencing. The effects of nonsynonymous variants on recombinant protein catalytic activity were investigated in vitro with Sf12 system. The haplotype of novel nonsynonymous variants with other single nucleotide variants in the same allele was determined using Nanopore sequencing. Of 38 alleles listed on the Pharmacogene Variation Consortium, we detected 7 previously reported alleles and 18 novel variants, of which 11 nonsynonymous variants showed lower catalytic activity (0.00-0.60) on bupropion compared to CYP2B6*1. Further, these 11 novel star-alleles (CYP2B6*39-49) were assigned by the Pharmacogene Variation Consortium, which may be valuable for pharmacogenetic research and personalized medicine.